GENSPEED-Schriftzug inkl. dem Slogan 'Fast Results to Drive Decisions'

Genspeed®

Fast Results to Drive Decisions

Compact, simple and fast – this is GENSPEED.

We offer the Genspeed technology platform with its universal applicability as an OEM solution for test manufacturers who want to open up new markets or need to fulfil the upcoming (regulatory) requirements for rapid testing.

Our Genspeed product portfolio ranges from COVID-19 and TBE (tick-borne encaphalitis) antibody tests to the direct detection of periodontitis pathogens in the dental office (dental products).

xPOC - multiplexed biomarker quantification

Just a drop of blood

Measuring the concentration of multiple biomarkers in just one drop of blood and in only 15 minutes. The unique GENSPEED xPOC Immuno Multiplex technology enables the  next step towards personalized medicine. Quantify up to 8 biomarkers in parallel in just 50µl of capillary blood. Open up new market perspectives and put your assays on the CE-IVD certified GENSPEED OEM platform technology!

SOON AVAILABLE - Vitamin D xPOC

The GENSPEED Vitamin D xPOC test provides results in laboratory quality from one drop of blood within 20 minutes. Results from the performance evaluation study confirm excellent consistency with comparison laboratory methods:
Pearson correlation coefficient of 0,88 for ELISA and 0,86 for HPLC.

The GENSPEED Vitamin D xPOC will be available soon.

NOW AVAILABLE - TBE (tick-borne encephalitis) Antibodytest

Cover FSME neu

Within 20 minutes the GENSPEED FSME IgG xPOC antibody test provides results on vaccine induced protection against TBE (tick-borne encephalitis) in lab quality. Results from the clinical evaluation study substantiated this giving a sensitivity of 99,3% and a specificity of 100%.

The GENSPEED FSME IgG xPOC is now available – find out more –>  FSME IgG xPOC

GENSPEED COVID-19 Antibodytest available!

COVID19 cover virus

Within 15 minutes, the GENSPEED COVID-19 IgG xPOC test delivers lab-quality results, as was impressively demonstrated in a study conducted by the Medical Faculty of the Johannes Kepler University Linz with a sensitivity of 100% compared to six laboratory ELISA methods published in the Journal of Clinical Virology. The Genspeed COVID-19 IgG xPOC antibody test is now available. More information can be found in the COVID-19 IgG xPOC brochure  

ORF report about the visit of the governor of Upper Austria to GENSPEED. During a tour of the company, Governor Thomas Stelzer mentioned mobile care, borders and air traffic as possible areas of application. "As long as this disease is there, the focus will be on testing and, above all, on fast results," Stelzer said in an ORF report.